Novo Nordisk, the manufacturer of Wegovy (semaglutide), has announced a new, higher dose: 7.2mg. Until now, the maximum licensed dose of Wegovy has been 2.4mg but new trial data shows that this higher strength could offer even greater weight loss results, rivalling medications like Mounjaro.
Although 7.2mg isn’t yet available in the UK, it’s generating serious interest across Europe following promising results from the STEP UP trials. Here’s what we know so far, who it’s for, how it compares, and when you might be able to access it through private providers like Voy.
Wegovy 7.2mg: results and how it compares
Wegovy 2.4mg is already proven to help many people lose significant weight, but it can take time for some to reach their goals on that dose. For those who plateau or need a stronger appetite suppressant, Wegovy 7.2mg could be a game changer.
Two new trials STEP UP and STEP UP T2D looked at the 7.2mg dose in people with obesity, with and without type 2 diabetes. The results were striking:
- Average total weight loss: up to 20.7% of body weight
- Around one-third of users lost 25% or more of their starting weight
- Data also showed that semaglutide 7.2mg was well tolerated, with a safety profile consistent with the 2.4mg dose and earlier semaglutide trials from Novo Nordisk
This places Wegovy 7.2mg in the same league as Mounjaro 15mg in terms of outcomes.
For comparison:
Thinking about switching? Compare weight loss options.
Who might benefit from Wegovy 7.2mg?
Wegovy 7.2mg is designed for people who need more support than the standard 2.4mg dose. It’s not a starting dose, but it could be the right next step if your progress has slowed or plateaued and you’re still tolerating semaglutide well.
This dose has been specifically studied for people who hadn’t achieved sufficient weight loss on lower doses of semaglutide. If that sounds like your experience, intensifying treatment with 7.2mg could help you get back on track.
You may be a good candidate if:
- You're currently on Wegovy 2.4mg, and your weight loss has plateaued.
- You’re tolerating semaglutide well, with mild or manageable side effects.
- You’ve been using Mounjaro but haven't seen the results you expected and you're considering switching to Wegovy.
- You’re experiencing side effects on Mounjaro and want to explore an alternative weight loss treatment.
Just a note: Wegovy 7.2mg isn’t a starting dose. If you’re switching from Mounjaro or beginning treatment with Wegovy for the first time, you’ll need to follow a titration plan agreed with your clinician before becoming eligible for this higher dose.
When will Wegovy 7.2mg be available?
The new 7.2mg dose of Wegovy hasn’t launched yet but it’s on the way. In July 2025, Novo Nordisk submitted an application to the European Medicines Agency (EMA) to make the higher dose available across Europe, including the UK. There’s no official update yet on US approval or an FDA submission.
The 7.2mg dose is expected to be available on Voy later this year. If you’re starting treatment now, the 7.2mg dose might be available by the time you’d typically reach that stage, so there will be no delay to your progress.
We’ll update our Wegovy weight loss injections page as soon as the new dose becomes available.
How much will it cost?
Final pricing for the 7.2mg dose hasn’t been confirmed just yet. As soon as we know more, we’ll update this page.
In the meantime, you can:
- Check if you're eligible for treatment
- Compare pricing plans and see what suits you best
Can I switch to Wegovy 7.2mg?
Not just yet. The 7.2mg dose hasn’t launched in the UK, but it’s expected later this year. Once available, there are a few different routes you might take to reach it, depending on your current treatment.
If you're already using Wegovy:
You may be able to move up to 7.2mg if you’re currently on the 2.4mg dose and need a little bit more support to reach your goal weight. If you’ve been tolerating the medication well with minimal side effects, your clinician may recommend increasing to 7.2mg once it's available.
If you’re on a lower Wegovy dose (such as 0.5mg, 1.0mg, or 1.7mg), you would need to continue titrating up to 2.4mg first. From there, your provider will assess whether you’re a good candidate to move on to 7.2mg.
If you're switching from Mounjaro:
You can speak to your provider about transitioning to Wegovy. If suitable, they will guide you through the appropriate titration schedule to reach 7.2mg.
At Voy, your clinician will work with you to determine whether this dose is right for you based on your progress, side effects, and goals.
What if I’m happy with my current dose?
If you're seeing good results on your current dose, with steady weight loss, strong appetite control, and minimal side effects, there’s no need to change. You don’t have to move up to a higher dose like 7.2mg unless you feel you need more appetite suppression.
If things ever plateau in the future or your goals change, you can always speak to your clinician about whether increasing your dose might be the right next step once 7.2mg becomes available.
Side effects of Wegovy 7.2mg
The most common side effects with Wegovy 7.2mg are digestive ones, including nausea, constipation, and diarrhoea. These are similar to what’s seen at the 2.4mg dose and with other GLP-1 medications like Mounjaro. They’re typically mild to moderate in severity and tend to settle over time as the body adjusts to the higher dose.
Some people also reported symptoms like tingling or skin sensitivity (known as dysesthesia). These occurred more frequently at the higher dose, but most were mild to moderate. Reassuringly, over 85% of people recovered while staying on treatment.
In terms of overall tolerability, Wegovy 7.2mg performed well. In the STEP UP trial:
- 5.4% of users on 7.2mg stopped treatment due to side effects
- This compares to 4.0% on 2.4mg
- And 6.2% on Mounjaro 15mg in separate studies
If you’re already tolerating Wegovy well, there’s a good chance you’ll do well on 7.2mg too. Just keep in mind that as doses increase, side effects may become more noticeable in the first few weeks while your body adjusts.
Why choose Voy?
If you're thinking about starting Wegovy 7.2mg, you're in expert hands with Voy. We're not just a prescription service, we're your partner throughout your entire weight loss journey.
Here's what sets us apart:
- Free, fast delivery — straight to your door in secure, discreet packaging
- Support within minutes — speak to a clinician on our hotline or via live chat
- Smart in-app tools — track your weight, appetite, and progress, log injection days, and access expert content including videos, tips, and nutrition advice
- 1-to-1 personalised coaching — expert support across nutrition, behaviour, and lifestyle
- Money-back guarantee — if it’s not right for you, we’ll help you find what is
Thousands of patients trust Voy for safe, clinically-backed weight loss and we’re here to help you reach your goals too. Take this short quiz to see if our programme could be the right fit for you.
¹